Imricor Launches Cardiovascular Unit to Expand iMR Use in Cardiac Catheterization

MT Newswires Live08-04

Imricor Medical Systems (ASX:IMR) launched Imricor Cardiovascular, a new business vertical designed to broaden the application of interventional magnetic resonance (iMR) in cardiac catheterization alongside its existing electrophysiology and ablation portfolio, according to a late Monday statement by the company.

The platform enables US hospitals to perform radiation-free cardiac catheterization by integrating magnetic resonance imaging and catheterization into a single procedure.

The approach is expected to shorten procedure time for each patient by around 35%, enhancing hospital efficiency while increasing available capacity in X-ray catheterization laboratories.

The company said the technology particularly benefits pediatric and congenital heart patients by enabling repeated catheterizations without ionizing radiation while improving imaging and reducing anesthesia use.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment